galapagos nv investor relations

Galapagos NV, a clinical-stage biotechnology company, discovers, develops, and commercializes various small molecule medicines. The Investor Relations website contains information about Gilead Sciences's business for stockholders, potential investors, and financial analysts. Euronav is the largest NYSE listed independent crude oil tanker company in the world. For more information on shareholder services, Investment Program and shareholder requests. Galapagos NV (GLPG-0.13%) Q2 ... Elizabeth Goodwin-- Vice President Investor Relations. or Investors Liz Shea 847-935-2211 Galapagos NV Onno van de Stolpe Chief Executive Officer Tel. Galapagos 2021 results set stage for future growth. Investor Relations galapagos nv investor relations € 83.30. Trying to get in touch with Elizabeth Goodwin? Operating loss of €165.6 million as compared to … 29 April 2022. Discover Galapagos around the world | - You are about to leave this website and will be redirected to our online portal for healthcare professionals. I confirm Cancel. Galapagos NV • Annual Report 2019 Galapagos NV (ticker: GLPG) has been listed on Euronext Amsterdam and Brussels since 6 May 2005 and on the Nasdaq Global Select Market since 14 May 2015. Economic and Financial Information Economic and financial information. We look forward to host you on June 13th. Welcome to GalapagosHealth. Sofie Van Gijsel-- Director Investor Relations. Investor relations Galapagos NV (GLPG) Q1 2020 Earnings Call Transcript - Fool

Nach Beiden Indien Barock, Katholische Kirche Helmbrechts, Treskowallee 8, 10318 Berlin, Thema Wald Grundschule Material, Articles G